BioAtla, Inc. Reports 2026 Annual Meeting Voting Results

What Happened
BioAtla, Inc. announced the voting results from its Annual Meeting of Stockholders held online on July 16, 2026. Holders of 906,983 shares (about 55% of outstanding eligible shares) were present in person virtually or by proxy. Stockholders elected two Class III directors—Jay M. Short, Ph.D. and Edward Williams—to three-year terms, ratified Ernst & Young LLP as the company’s independent registered public accounting firm for fiscal 2026, and approved, on a non-binding advisory basis, the executive compensation of the named executive officers.

Key Details

• Meeting date: July 16, 2026; total shares represented: 906,983 (~55% of outstanding).
• Election of directors (three-year terms):
  • Jay M. Short, Ph.D.: 313,903 votes for; 132,916 withheld; 460,164 broker non-votes.
  • Edward Williams: 309,949 votes for; 136,870 withheld; 460,164 broker non-votes.
• Ratification of auditor (Ernst & Young LLP): 869,667 votes for; 18,545 against; 18,771 abstentions.
• Non-binding advisory vote on executive compensation: 281,294 for; 96,492 against; 69,033 abstentions; 460,164 broker non-votes.

Why It Matters
Board continuity was maintained with the re-election of two directors, and auditor continuity was affirmed by ratifying Ernst & Young for fiscal 2026—both are governance items investors track for oversight and financial reporting stability. The advisory “say-on-pay” was approved, though non-binding; investors should note the substantial number of broker non-votes on director and compensation items, which can indicate that many institutional or unvoted shares did not participate in those specific votes.